Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration placed a clinical hold on two of Collectis' clinical trials for an immunotherapy drug after a patient's death, reports Genetic Engineering & Biotechnology News.
Hospira recalled one lot of Hydromorphone, a pain medication, and four lots of the blood pressure drug Levophed Thursday due to a potential lack of sterility assurance.
Here are six drugmakers that made headlines in the past week.
Novartis, a Swiss pharmaceutical company, named its Global Head of Drug Development and CMO Vasant Narasimhan, MD, successor to current CEO Joe Jimenez, who will step down Jan. 31.
Teleflex, a medical device maker, will purchase NeoTract, a urology device manufacturer, for up to $1.1 billion, according to Reuters.
The Food and Drug Administration has approved 31 new drugs so far in 2017, with a handful of regulatory decisions scheduled for this month, according to Zacks Investment Research.
McKesson Corp. and the McKesson Foundation donated more than $300,000 to support hurricane relief efforts in Texas.
St. Louis-based Mercy Health's supply chain organization Resource Optimization & Innovation on Friday acquired Orlando, Fla.-based Healthcare Purchasing Alliance.
Travelers should expect high gas prices and shortages this Labor Day weekend, as Hurricane Harvey has hindered operations at some of largest fuel pipelines and oil refineries in the U.S., reports Reuters.
The death of five patients using balloon obesity devices most caught reader's attention last month.